Content about Branded

December 2, 2010
Oramed announces publication in diabetes journal

Oramed Pharmaceuticals, a developer of oral drug delivery solutions, has published an article in the Journal of Diabetes Science and Technology’s November issue describing evaluation of the company’s glucagon-like peptide (GLP-1) analog formulation (ORMD-0901) in regulating glucose excursions in animal models.

December 1, 2010
Endo completes Qualitest acquisition

Endo Pharmaceuticals has finished its acquisition of Qualitest Pharmaceuticals for $1.2 billion, Endo said Wednesday.

December 1, 2010
Keryx: Zerenex reduces phosphate levels in patients on kidney dialysis

Drug maker Keryx Biopharmaceuticals got promising results from a late-stage clinical trial of a drug for treating elevated phosphate levels, also known as hyperphosphatemia, in patients on kidney dialysis, the company said Tuesday.

December 1, 2010
Watson's Ella enters market

Drug maker Watson Pharmaceuticals has made an emergency oral contraceptive available by prescription in the United States, the company said Wednesday.

November 30, 2010
Merck's president steps in as new CEO

The president of drug maker Merck now will fill an additional position at the company: CEO.

November 30, 2010
Relationship between industry, FDA is strained, PwC report finds

Recent public perception that the Food and Drug Administration had not been doing its job — ensuring that Americans' approved medical devices and medicines are relatively safe — may be impeding fast approval processes, according to a new PricewaterhouseCoopers report published Tuesday.

November 29, 2010
FDA review of MS drug extended, EMD Serono says

The Food and Drug Administration has extended its review period for a multiple sclerosis drug made by EMD Serono, the drug maker said Friday.

November 29, 2010
Walgreens' Pegus to discuss impact of diabetes management on healthcare costs

Walgreens' chief medical officer will discuss the evidence-based medicine design and impact of a diabetes management program delivered by pharmacists at both workplace and community pharmacies during an upcoming conference, the drug store chain said.

November 24, 2010
Antiviral drugs could cause insulin resistance, study finds

Since the beginning of the HIV/AIDS epidemic in the early 1980s, one of the greatest advances has been antiviral drugs that have helped extend the lives of patients with viral infections.

November 24, 2010
FDA approves Axiron

Eli Lilly and Australian drug maker Acrux have received approval from the Food and Drug Administration for a testosterone replacement therapy for men, the two companies announced Tuesday.

November 24, 2010
Study: Depression may be both a risk factor and consequence of diabetes

A new study published in the Nov. 22 issue of Archives of Internal Medicine suggested there is a two-way relationship between depression and diabetes.

November 24, 2010
UnitedHealthcare partners with Kroger, Safeway on $2 generic Part D plan

UnitedHealth Group will start a program next year that it said can reduce drug costs to as low as $2 per script, the company said Tuesday.

November 22, 2010
New drug from Gilead may prevent HIV infection, study finds

NEW YORK A daily dose of an anti-retroviral pill appears to prevent HIV infection, according to results of a study conducted by University of California at San Francisco researchers, published in The New England Journal of Medicine on Tuesday.

November 21, 2010
Deadline for Pfizer's tender offer for King extended

Pfizer has extended the deadline of its $3.6 billion offer to buy King Pharmaceuticals, Pfizer...

November 21, 2010
FDA asks Xanodyne to pull painkillers from market

A drug maker will pull a common prescription painkiller from the market following the release...

November 21, 2010
OcuSoft's Zytaze now available at chain drug stores

Drug maker OcuSoft has launched a prescription supplement designed to enhance botulinum toxin injections, the...

November 21, 2010
Vytorin helps reduce cardiac events in chronic kidney disease patients

A cholesterol-lowering drug made by Merck appears to reduce the risk of heart attacks, strokes...

November 18, 2010
Amgen's Xgeva receives FDA approval

The Food and Drug Administration has approved a treatment for preventing skeletal injuries in patients...

November 17, 2010
Byetta may cut cardiovascular risk for diabetes patients

A Type 2 diabetes drug marketed by Eli Lilly and Amylin Pharmaceuticals may lower the...

November 16, 2010
FDA advisory committee recommends expanded use of Gardasil

A Food and Drug Administration advisory committee has recommended expanded approval of a vaccine for...

November 15, 2010
Generic versions of Alimta, Abilify get shut down by district courts

The U.S. District Court for the District of Delaware has upheld a patent held by...

November 14, 2010
FDA approves ADHD drug for adolescents

The Food and Drug Administration has approved an attention deficit hyperactivity disorder drug for use...

November 14, 2010
FDA approves new breast cancer treatment

The Food and Drug Administration has approved a new treatment for breast cancer, the agency...

November 14, 2010
Out-of-pocket costs vary widely for branded, generic drugs

The often wide gap between what consumers will pay out of pocket for a branded...

November 14, 2010
Patent cliff to bring short-term boon to generic industry

Look for a big surge in brand-to-generic drug switches at the pharmacy counter over the...

© 2013 Drug Store News. All Rights Reserved.